Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 118.00M | $ 73.00M | $ 72.00M | $ 154.00M | $ 196.00M |
Total Assets | $ 9.12B | $ 9.84B | $ 9.20B | $ 8.88B | $ 10.31B |
Total Debt | $ 2.04B | $ 2.75B | $ 2.45B | $ 2.54B | $ 3.31B |
Net Debt | $ 1.92B | $ 2.67B | $ 2.38B | $ 2.39B | $ 3.12B |
Total Liabilities | $ 2.52B | $ 3.11B | $ 2.95B | $ 2.89B | $ 3.93B |
Stockholders Equity | $ 6.58B | $ 6.72B | $ 6.23B | $ 5.92B | $ 6.29B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |